• About us
• Contact

Advertisement

Product › Details

immunotherapy

	Next higher product group	pharmaceutical

Record changed: 2024-09-20

Advertisement

More documents for immunotherapy

• [1] Medigene AG. (2/27/25). "Press Release: Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers". Planegg....
• [2] Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT....
• [3] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
• [4] Harpoon Therapeutics, Inc.. (10/23/23). "Press Release: Harpoon Therapeutics Announces up to $150 Million Private Placement". South San Francisco, CA....
• [5] BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem....
• [6] BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem....
• [7] Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY....
• [8] Takeda Pharmaceutical Co. Ltd.. (3/9/22). "Press Release: Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio". Osaka & Brisbane, CA....
• [9] Takeda Pharmaceutical Co. Ltd.. (1/10/22). "Press Release: Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (gd) T Cell Engager Therapies Targeting Solid Tumors". Osaka & London....
• [10] Biond Biologics Ltd.. (1/8/19). "Press Release: Biond Biologics Announces $17 Million Series B Financing". Misgav....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.